Brief description

China is one of the largest pharmaceutical markets in the world. In 2018, the size of China’s generic drug market was $85 billion and growing with more than 90% of the drugs registered in China as generic. The size of Chinese market presents a golden opportunity for overseas drug companies, but the fast-changing regulations and 4+7 centralised procurement system make it critical to understand how to navigate the China regulatory and market environment. Click now to register for the webinar to learn more.

PLG Keynote Speaker: Sylvie Dinh, Head of Development Services
PLG Keynote Speaker: Sylvie Dinh, Head of Development Services

Register to our news and events

Go to our Events to register
Go to our News to get insights

China Generic Drug Market & Registration (ANDA)